JPRN-UMIN000011976Completed未知
Observation study to examine the efficacy of 500mg Fluvestrant that targets ER(+) postmenopausal metastatic breast cancer patients (>1st line). - PerSeus -BC03
PerSeUS:Perpetual Study estimated -by United Sections in Gifu0 sitesStarted: October 7, 2013Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- Female
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1.Life threatening including large liver metastasis, larege brain metastasis, systematic inflammatory lymphangitis in lung. 2.Inflammatory breast cancer 3.Previous therapy by Fluvestrant. 4.Patients who accetted >4th ET. 5. Allergy to Fluvestrant. 6.Patients considered ineligible by the attending physician.
Investigators
Similar Trials
Completed
Not Applicable
Observational study to assess dose-up efficacy of anticholinergic agent on nocturia in overactive bladder patientsOveractive bladderJPRN-UMIN000012640Clinical Research Support Center Kyushu100
Recruiting
Not Applicable
Prospective clinical study to evaluate efficacy of ICOLENS TM, a bifocal corneal implant to treat presbyopiaH52.4PresbyopiaDRKS00000459eoptics AG30
Completed
Unknown
A clinical study for evaluating the effects of food containing lactic acid bacteria on common cold symptoms - A randomized, double-blind, placebo-controlled, parallel-group comparative methodHealthy AdultsJPRN-UMIN000049183KSO Corporation200
Completed
Unknown
A clinical study for evaluating the effects of food containing lactic acid bacteria on immune function. - A randomized, double-blind, placebo-controlled, parallel-group comparative methodHealthy AdultsJPRN-UMIN000045901KSO Corporation200
Not yet recruiting
Unknown
A clinical study for evaluating the effects of food containing lactic acid bacteria on defecation.-A randomized, double-blind,placebo-controlled, parallel-group comparative studyJPRN-UMIN000048911ew drug research center, Inc.80